➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Johnson and Johnson
Harvard Business School
Dow
Merck

Last Updated: October 27, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021488


Email this page to a colleague

« Back to Dashboard

NDA 021488 describes ELIGARD KIT, which is a drug marketed by Tolmar Therap and is included in four NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the ELIGARD KIT profile page.

The generic ingredient in ELIGARD KIT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 021488
Tradename:ELIGARD KIT
Applicant:Tolmar Therap
Ingredient:leuprolide acetate
Patents:1
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021488
Suppliers and Packaging for NDA: 021488
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELIGARD KIT leuprolide acetate POWDER;SUBCUTANEOUS 021488 NDA TOLMAR PHARMACEUTICALS INC. 62935-303 62935-303-30 1 KIT in 1 CARTON (62935-303-30) * .5 mL in 1 SYRINGE (62935-305-29) * .5 mL in 1 SYRINGE (62935-304-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;SUBCUTANEOUSStrength30MG
Approval Date:Feb 13, 2003TE:RLD:Yes
Patent:⤷  Try it FreePatent Expiration:Oct 15, 2023Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF TREATING CANCER

Expired US Patents for NDA 021488

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tolmar Therap ELIGARD KIT leuprolide acetate POWDER;SUBCUTANEOUS 021488-001 Feb 13, 2003 ⤷  Try it Free ⤷  Try it Free
Tolmar Therap ELIGARD KIT leuprolide acetate POWDER;SUBCUTANEOUS 021488-001 Feb 13, 2003 ⤷  Try it Free ⤷  Try it Free
Tolmar Therap ELIGARD KIT leuprolide acetate POWDER;SUBCUTANEOUS 021488-001 Feb 13, 2003 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Baxter
Dow
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.